Scancell
Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer.
57 employees · est. 1996 · Oxford, United Kingdom
SynOx Therapeutics
Our mission is to focus on the unmet clinical needs of patients suffering from Tenosynovial Giant Cell Tumours (TGCT)
29 employees · est. 2020 · Ireland
Scancell is the older company (1996 vs 2020); Scancell is the larger of the two.
Side-by-Side Comparison
| Metric | Scancell | SynOx Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 1996 older | 2020 |
| Headquarters | ||
| Headquarters | Oxford, United Kingdom | Ireland |
| Employees | ||
| Employees | 57 larger | 29 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Debt Financing |
| Total Funding | ||
| Total Funding | $15.65M | $147.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | Not tracked yet | Development of emactuzumab, Treatment of TGCT, Macrophage-mediated disease solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with TGCT, Healthcare Providers, Biotech Researchers |
| Taxonomy | ||
| Taxonomy | Immunology, Cancer, ImmunoBody, Moditope, Cancer Vaccines, AvidiMab, GlyMab, Antibody Platforms, Tumours, Immune System, Cancer Treatment, Prevention, Biopharmaceuticals | Research, Emactuzumab, TGCT Treatment, Tenosynovial Giant Cell Tumours, Diffuse Tumours, Biopharma Development, Clinical Needs, Therapeutic Development, Investor-backed, Biopharmaceuticals, Tumour Treatment, Health Innovation |
| Website | ||
| Website | scancell.co.uk | synoxtherapeutics.com |
About Scancell
Scancell Ltd is a UK-based startup dedicated to using immunology to fight cancer. Established in 1996, the company focuses on developing innovative products that stimulate the immune system to treat or prevent cancer. Operating in the biotechnology and healthcare industries, Scancell aims to address...
About SynOx Therapeutics
SynOx Therapeutics, an innovative player in the Biotechnology and Health and Wellness sectors, is strategically positioned to address critical needs in cancer treatment. Founded in November 2020, this Ireland-based company is committed to developing emactuzumab for the treatment of diffuse tenosynov...
We will tell you when either one moves
BounceWatch watches Scancell and SynOx Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Scancell and SynOx Therapeutics — by email.
Frequently Asked Questions
Compare Scancell with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Scancell on 12 Sep 2024, and SynOx Therapeutics on 18 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.